Editorial
doi: 10.1200/JCO.2012.44.1949.
Epub 2012 Aug 20.
Oxaliplatin as part of adjuvant therapy for colon cancer: more complicated than once thought
- PMID: 22915653
- DOI: 10.1200/JCO.2012.44.1949
Item in Clipboard
Editorial
Oxaliplatin as part of adjuvant therapy for colon cancer: more complicated than once thought
J Clin Oncol.
.
No abstract available
Comment in
-
Adjuvant chemotherapy for stage II colon cancer: less complicated than we thought.J Clin Oncol. 2013 Apr 20;31(12):1611. doi: 10.1200/JCO.2012.47.2852. Epub 2013 Mar 18. J Clin Oncol. 2013. PMID: 23509312 No abstract available.
-
Disease-free survival in colon cancer: still relevant after all these years!J Clin Oncol. 2013 Apr 20;31(12):1609-10. doi: 10.1200/JCO.2012.47.4452. Epub 2013 Mar 18. J Clin Oncol. 2013. PMID: 23509315 No abstract available.
-
Reply to A. Grothey et al and R.S. Midgley et al.J Clin Oncol. 2013 Apr 20;31(12):1612-3. doi: 10.1200/JCO.2012.47.8859. J Clin Oncol. 2013. PMID: 23734371 No abstract available.
Comment on
-
Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial.J Clin Oncol. 2012 Sep 20;30(27):3353-60. doi: 10.1200/JCO.2012.42.5645. Epub 2012 Aug 20. J Clin Oncol. 2012. PMID: 22915656
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
